• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新加坡嗜铬细胞瘤和副神经节瘤的临床管理:基因检测错失的机会

Clinical management of pheochromocytoma and paraganglioma in Singapore: missed opportunities for genetic testing.

作者信息

Chew Winston Hong Wern, Courtney Eliza, Lim Kok Hing, Li Shao Tzu, Chen Yanni, Tan Min Han, Chung Alexander, Khoo Joan, Loh Amos, Soh Shui Yen, Iyer Prasad, Loh Lih Ming, Ngeow Joanne

机构信息

Cancer Genetics ServiceDivision of Medical OncologyNational Cancer Centre SingaporeSingapore City169610Singapore.

Department of PathologySingapore General HospitalSingapore City169610Singapore.

出版信息

Mol Genet Genomic Med. 2017 Jul 20;5(5):602-607. doi: 10.1002/mgg3.313. eCollection 2017 Sep.

DOI:10.1002/mgg3.313
PMID:28944243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5606879/
Abstract

BACKGROUND

Pheochromocytomas and paragangliomas (PPGLs) are neuroendocrine tumors of the adrenal glands and paraganglia, occurring sporadically or as a range of hereditary tumor syndromes. About 30% of PPGLs are attributed to germline mutations. Clinical presentation, including localization, malignant potential, and age of onset, varies depending on the genetic background. Genetic testing for PPGLs is not well studied in Southeast Asia. We reviewed clinical management of PPGLs in Singapore, highlighting current gaps in clinical practice.

METHODS

Medical records of patients with PPGLs between 2005 and 2016 were reviewed. Diagnosis was confirmed histologically and stratified into sporadic or familial/syndromic (FS).

RESULTS

Twenty-seven (21.8%) patients were referred to the Cancer Genetics Service (CGS). FS PPGLs (18.5%) and extra-adrenal PPGLs (58.1%) incidences were higher than previous studies. Referrals were lower for sporadic PPGLs compared to FS PPGLs (3.7% vs. 100%). Referrals were highest at diagnosis age <20 years old (80%) and decreased with increasing age; ≥20-<40 years old (32.1%), ≥40-<60 years old (10.6%). Genetic testing was taken up in 12/27 (44.4%) patients of which 7/12 (58.3%, ) had germline mutations.

CONCLUSION

Opportunities for genetic testing are frequently missed due to low referral rates in patients with apparently sporadic PPGLs, particularly between ages 20-60.

摘要

背景

嗜铬细胞瘤和副神经节瘤(PPGLs)是肾上腺和副神经节的神经内分泌肿瘤,可散发发生或作为一系列遗传性肿瘤综合征出现。约30%的PPGLs归因于种系突变。临床表现,包括定位、恶性潜能和发病年龄,因遗传背景而异。PPGLs的基因检测在东南亚地区研究较少。我们回顾了新加坡PPGLs的临床管理情况,突出了当前临床实践中的差距。

方法

回顾了2005年至2016年期间PPGLs患者的病历。诊断经组织学证实,并分为散发性或家族性/综合征性(FS)。

结果

27例(21.8%)患者被转诊至癌症遗传学服务(CGS)。FS-PPGLs(18.5%)和肾上腺外PPGLs(58.1%)的发病率高于先前研究。散发性PPGLs的转诊率低于FS-PPGLs(3.7%对100%)。转诊率在诊断年龄<20岁时最高(80%),并随年龄增加而降低;≥20-<40岁(32.1%),≥40-<60岁(10.6%)。27例患者中有12例(44.4%)接受了基因检测,其中12例中有7例(58.3%)发生了种系突变。

结论

由于明显散发性PPGLs患者的转诊率较低,尤其是在20-60岁之间,基因检测的机会经常被错过。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf55/5606879/9f57227ee5ce/MGG3-5-602-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf55/5606879/9f57227ee5ce/MGG3-5-602-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf55/5606879/9f57227ee5ce/MGG3-5-602-g001.jpg

相似文献

1
Clinical management of pheochromocytoma and paraganglioma in Singapore: missed opportunities for genetic testing.新加坡嗜铬细胞瘤和副神经节瘤的临床管理:基因检测错失的机会
Mol Genet Genomic Med. 2017 Jul 20;5(5):602-607. doi: 10.1002/mgg3.313. eCollection 2017 Sep.
2
Germline mutations and genotype-phenotype correlations in patients with apparently sporadic pheochromocytoma/paraganglioma in Korea.韩国散发性嗜铬细胞瘤/副神经节瘤患者的胚系突变及基因型-表型相关性
Clin Genet. 2014 Nov;86(5):482-6. doi: 10.1111/cge.12304. Epub 2013 Nov 15.
3
Genetic spectrum in a Canadian cohort of apparently sporadic pheochromocytomas and paragangliomas: New data on multigene panel retesting over time.加拿大一组貌似散发的嗜铬细胞瘤和副神经节瘤患者的遗传谱:随着时间推移对多基因 panel 重新检测的新数据。
Clin Endocrinol (Oxf). 2022 Jun;96(6):803-811. doi: 10.1111/cen.14618. Epub 2021 Nov 8.
4
15 YEARS OF PARAGANGLIOMA: Genetics and mechanism of pheochromocytoma-paraganglioma syndromes characterized by germline SDHB and SDHD mutations.15年的副神经节瘤研究:以种系SDHB和SDHD突变为特征的嗜铬细胞瘤-副神经节瘤综合征的遗传学及机制
Endocr Relat Cancer. 2015 Aug;22(4):T71-82. doi: 10.1530/ERC-15-0226. Epub 2015 Jun 25.
5
Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.半定量¹²³I-间碘苄胍闪烁扫描术鉴别嗜铬细胞瘤和副神经节瘤与生理性肾上腺摄取及其与儿茶酚胺转运体基因型依赖性表达的相关性
J Nucl Med. 2015 Jun;56(6):839-46. doi: 10.2967/jnumed.115.154815. Epub 2015 Apr 16.
6
Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients.基于329例患者的研究结果对单发嗜铬细胞瘤和副神经节瘤进行体细胞和生殖系基因检测的建议
J Med Genet. 2015 Oct;52(10):647-56. doi: 10.1136/jmedgenet-2015-103218. Epub 2015 Aug 12.
7
Genetics and imaging of pheochromocytomas and paragangliomas: current update.嗜铬细胞瘤和副神经节瘤的遗传学和影像学:最新研究进展。
Abdom Radiol (NY). 2020 Apr;45(4):928-944. doi: 10.1007/s00261-019-02044-w.
8
Correlation between in vivo 18F-FDG PET and immunohistochemical markers of glucose uptake and metabolism in pheochromocytoma and paraganglioma.18F-FDG PET 显像与嗜铬细胞瘤和副神经节瘤葡萄糖摄取和代谢的免疫组化标志物的相关性。
J Nucl Med. 2014 Aug;55(8):1253-9. doi: 10.2967/jnumed.114.137034. Epub 2014 Jun 12.
9
Review: Should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes?综述:对于明显散发的嗜铬细胞瘤或副神经节瘤患者,是否应筛查遗传性综合征?
J Clin Endocrinol Metab. 2006 Aug;91(8):2851-8. doi: 10.1210/jc.2005-2178. Epub 2006 May 30.
10
Disentangling of Malignancy from Benign Pheochromocytomas/Paragangliomas.鉴别恶性嗜铬细胞瘤/副神经节瘤与良性嗜铬细胞瘤/副神经节瘤
PLoS One. 2016 Dec 16;11(12):e0168413. doi: 10.1371/journal.pone.0168413. eCollection 2016.

引用本文的文献

1
Genetic Testing Referral Rates for Pheochromocytoma and Paraganglioma in an Academic Tertiary Centre.学术三级中心嗜铬细胞瘤和副神经节瘤的基因检测转诊率
Clin Endocrinol (Oxf). 2025 Aug;103(2):147-156. doi: 10.1111/cen.15248. Epub 2025 Apr 15.
2
Differences between Patients with Sporadic and Familial Pheochromocytoma-Is It Possible to Avoid Genetic Testing in Certain Patients?散发性和家族性嗜铬细胞瘤患者之间的差异——某些患者是否有可能避免基因检测?
Biomedicines. 2024 Jun 18;12(6):1352. doi: 10.3390/biomedicines12061352.
3
The role of the adrenalectomy in the management of pheochromocytoma: the experience of a Portuguese referral center.

本文引用的文献

1
Impact of subsidies on cancer genetic testing uptake in Singapore.补贴对新加坡癌症基因检测普及情况的影响。
J Med Genet. 2017 Apr;54(4):254-259. doi: 10.1136/jmedgenet-2016-104302. Epub 2016 Oct 25.
2
Predictors of malignancy in patients with pheochromocytomas/paragangliomas: Asian Indian experience.嗜铬细胞瘤/副神经节瘤患者恶性肿瘤的预测因素:亚洲印度人的经验。
Endocr Connect. 2016 Nov;5(6):89-97. doi: 10.1530/EC-16-0086. Epub 2016 Nov 16.
3
A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.
肾上腺切除术在嗜铬细胞瘤治疗中的作用:葡萄牙转诊中心的经验。
Endocrine. 2024 Oct;86(1):409-416. doi: 10.1007/s12020-024-03916-y. Epub 2024 Jun 8.
4
Carotid body tumor with neck metastasis due to germline variant: a case report and literature review.因胚系变异导致颈部转移的颈动脉体瘤:一例报告及文献综述
Int Cancer Conf J. 2021 Oct 31;11(1):6-11. doi: 10.1007/s13691-021-00522-x. eCollection 2022 Jan.
5
A 15-year pheochromocytoma and paraganglioma experience in a single centre: a Singapore perspective.一家中心 15 年嗜铬细胞瘤和副神经节瘤诊治经验:新加坡视角。
Singapore Med J. 2022 Nov;63(11):649-658. doi: 10.11622/smedj.2021135. Epub 2021 Oct 4.
6
Characteristics and genetic testing outcomes of patients with clinically suspected paraganglioma/pheochromocytoma (PGL/PCC) syndrome in Singapore.新加坡临床疑似副神经节瘤/嗜铬细胞瘤(PGL/PCC)综合征患者的特征及基因检测结果
Hered Cancer Clin Pract. 2020 Dec 11;18(1):24. doi: 10.1186/s13053-020-00156-9.
美国医学遗传学与基因组学学会及国家遗传咨询师协会的一份实践指南:癌症易感性评估的转诊指征
Genet Med. 2015 Jan;17(1):70-87. doi: 10.1038/gim.2014.147. Epub 2014 Nov 13.
4
Paraganglioma and phaeochromocytoma: from genetics to personalized medicine.副神经节瘤和嗜铬细胞瘤:从遗传学到个体化医学。
Nat Rev Endocrinol. 2015 Feb;11(2):101-11. doi: 10.1038/nrendo.2014.188. Epub 2014 Nov 11.
5
The value of (68)Ga-DOTATATE PET/CT in diagnosis and management of neuroendocrine tumors compared to current FDA approved imaging modalities: a review of literature.与目前美国食品药品监督管理局(FDA)批准的成像方式相比,(68)Ga-DOTATATE正电子发射断层显像/计算机断层扫描(PET/CT)在神经内分泌肿瘤诊断和管理中的价值:文献综述
Am J Nucl Med Mol Imaging. 2014 Aug 15;4(5):426-34. eCollection 2014.
6
Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.嗜铬细胞瘤和副神经节瘤:内分泌学会临床实践指南
J Clin Endocrinol Metab. 2014 Jun;99(6):1915-42. doi: 10.1210/jc.2014-1498.
7
Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity.嗜铬细胞瘤和副神经节瘤的发病机制:从遗传异质性中学习。
Nat Rev Cancer. 2014 Feb;14(2):108-19. doi: 10.1038/nrc3648. Epub 2014 Jan 20.
8
Long-term postoperative follow-up in patients with apparently benign pheochromocytoma and paraganglioma.貌似良性的嗜铬细胞瘤和副神经节瘤患者的长期术后随访。
Horm Metab Res. 2012 May;44(5):385-9. doi: 10.1055/s-0031-1301339. Epub 2012 Feb 20.
9
Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas.遗传性嗜铬细胞瘤和副神经节瘤的遗传学和临床特征。
Endocr Relat Cancer. 2011 Dec 1;18(6):R253-76. doi: 10.1530/ERC-11-0170. Print 2011 Dec.
10
Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD.358 例种系 SDHB 和 SDHD 基因突变患者的肿瘤风险和基因型-表型-生物型分析。
Hum Mutat. 2010 Jan;31(1):41-51. doi: 10.1002/humu.21136.